Supportive care in a patient with Alstrom syndrome with hyperphenylalaninemia and sleep problems.

Alstrom syndrome obesity polysomenography sleep apnea sleep medicine

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 08 07 2022
revised: 05 10 2022
accepted: 17 10 2022
entrez: 13 2 2023
pubmed: 14 2 2023
medline: 14 2 2023
Statut: epublish

Résumé

Alstrom syndrome is a rare genetic disorder with an autosomal recessive mutation in the ALMS1 gene. The disease's manifestations include ophthalmic problems, hearing loss, obesity, and cardiovascular disorders. In addition, medical cases include other organ complications. However, the overlapping variety of such symptoms with other diseases may delay the diagnosis. In this article, we describe the case of a 7-year-old female patient with Alstrom syndrome, and cardiovascular and hyperphenylalaninemia diseases since birth. Other symptoms included diabetes and ophthalmologic problems with skeletal disability. Blindness and hearing impairment were diagnosed, along with recurrence of respiratory problems at the age of 7 years. The patient's obesity-induced snoring predisposed her to uncontrolled blood glucose. In fact, respiratory tract problems and sleep disorders had occurred as a degraded cycle and left her with a severe disability for years. The similarity of the symptoms with other diseases had misled the physician in diagnosis. However, a polysomnography test (because of complaints of short sleep duration) recognized the source of the patient's sleep disorders and breathing problems. Eventually, we delivered a portable ventilator to the child for continuous positive airway pressure (CPAP) therapy. The child's breathing and oxygenation conditions improved. Using the ventilator and the CPAP system, we discharged her from the hospital without requiring oxygenation, in a stable condition. The procedure could prevent the patient from hypoxia and retinal problem.

Identifiants

pubmed: 36777792
doi: 10.1002/ccr3.6894
pii: CCR36894
pmc: PMC9900236
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e6894

Informations de copyright

© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Références

Sleep Med. 2022 Feb;90:9-16
pubmed: 35051737
Clin Endocrinol (Oxf). 2013 Oct;79(4):529-36
pubmed: 23445176
Clin Obes. 2022 Feb;12(1):e12493
pubmed: 34781415
Nephrol Dial Transplant. 2020 Jun 1;35(6):994-1001
pubmed: 30307515
Eur J Hum Genet. 2007 Dec;15(12):1193-202
pubmed: 17940554
J Pediatr. 1996 Feb;128(2):225-9
pubmed: 8636816
Orphanet J Rare Dis. 2020 Sep 21;15(1):253
pubmed: 32958032
J Clin Endocrinol Metab. 2018 Jul 1;103(7):2707-2719
pubmed: 29718281
J Am Soc Echocardiogr. 2007 Dec;20(12):1359-63
pubmed: 17825523
Pediatr Pulmonol. 2017 Apr;52(4):487-493
pubmed: 28029746
Curr Genomics. 2011 May;12(3):225-35
pubmed: 22043170

Auteurs

Shabnam Jalilolghadr (S)

Department of Pediatrics, School of Medicine, Children Growth Research Center, Research Institute for Prevention of Non-communicable Diseases Qazvin University of Medical Sciences Qazvin Iran.

Fatemeh Saffari (F)

Children Growth Research Center, Research Institute for Prevention of Non-communicable Diseases Qazvin University of Medical Sciences Qazvin Iran.

Mehdi Alizadeh (M)

Children Growth Research Center, Research Institute for Prevention of Non-communicable Diseases Qazvin University of Medical Sciences Qazvin Iran.

AliReza Taremiha (A)

Children Growth Research Center, Research Institute for Prevention of Non-communicable Diseases Qazvin University of Medical Sciences Qazvin Iran.

Marjan Ghodsi (M)

Azad University of Science and Research Tehran Iran.

Mersedeh Ghodsi (M)

Children Growth Research Center, Research Institute for Prevention of Non-communicable Diseases Qazvin University of Medical Sciences Qazvin Iran.
Iran University of Medical Sciences Tehran Iran.

Classifications MeSH